|
1
|
Kelsey CR, Das S, Gu L, Dunphy FR III,
Ready NE and Marks LB: phase 1 dose escalation study of accelerated
radiation therapy with concurrent chemotherapy for locally advanced
lung cancer. Int J Radiat Oncol Biol Phys. 93:997–1004. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chiappori AA, Kolevska T, Spigel DR, Hager
S, Rarick M, Gadgeel S, Blais N, Von Pawel J, Hart L, Reck M, et
al: A randomized phase II study of the telomerase inhibitor
imetelstat as maintenance therapy for advanced non-small-cell lung
cancer. Ann Oncol. 26:354–362. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Machtay M, Duan F, Siegel BA, Snyder BS,
Gorelick JJ, Reddin JS, Munden R, Johnson DW, Wilf LH, DeNittis A,
et al: Prediction of survival by [18F]fluorodeoxyglucose
positron emission tomography in patients with locally advanced
non-small-cell lung cancer undergoing definitive chemoradiation
therapy: Results of the ACRIN 6668/RTOG 0235 trial. J Clin Oncol.
31:3823–3830. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wu C, Li F and Jiao SC: Prognostic factors
for survival of patients with extensive stage small cell lung
cancer - a retrospective single institution analysis. Asian Pac J
Cancer Prev. 13:4959–4962. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Abhari K, Shekarforoush SS, Hosseinzadeh
S, Nazifi S, Sajedianfard J and Eskandari MH: The effects of orally
administered Bacillus coagulans and inulin on prevention and
progression of rheumatoid arthritis in rats. Food Nutr Res.
60:308762016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liao K, Li J and Wang Z:
Dihydroartemisinin inhibits cell proliferation via
AKT/GSK3β/cyclinD1 pathway and induces apoptosis in A549 lung
cancer cells. Int J Clin Exp Pathol. 7:8684–8691. 2014.PubMed/NCBI
|
|
7
|
Zhang Q, Zhu H, Xu X, Li L, Tan H and Cai
X: Inactivated Sendai virus induces apoptosis and autophagy via the
PI3K/Akt/mTOR/p70S6K pathway in human non-small cell lung cancer
cells. Biochem Biophys Res Commun. 465:64–70. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li YC, He SM, He ZX, Li M, Yang Y, Pang
JX, Zhang X, Chow K, Zhou Q, Duan W, et al: Plumbagin induces
apoptotic and autophagic cell death through inhibition of the
PI3K/Akt/mTOR pathway in human non-small cell lung cancer cells.
Cancer Lett. 344:239–259. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Saiki S, Sasazawa Y, Imamichi Y, Kawajiri
S, Fujimaki T, Tanida I, Kobayashi H, Sato F, Sato S, Ishikawa K,
et al: Caffeine induces apoptosis by enhancement of autophagy via
PI3K/Akt/mTOR/p70S6K inhibition. Autophagy. 7:176–187. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xiong F, Jiang M, Huang Z, Chen M, Chen K,
Zhou J, Yin L, Tang Y, Wang M, Ye L, et al: A novel herbal formula
induces cell cycle arrest and apoptosis in association with
suppressing the PI3K/AKT pathway in human lung cancer A549 cells.
Integr Cancer Ther. 13:152–160. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Trigka EA, Levidou G, Saetta AA,
Chatziandreou I, Tomos P, Thalassinos N, Anastasiou N, Spartalis E,
Kavantzas N, Patsouris E, et al: A detailed immunohistochemical
analysis of the PI3K/AKT/mTOR pathway in lung cancer: Correlation
with PIK3CA, AKT1, K-RAS or PTEN
mutational status and clinicopathological features. Oncol Rep.
30:623–636. 2013.PubMed/NCBI
|
|
12
|
Gadgeel SM and Wozniak A: Preclinical
rationale for PI3K/Akt/mTOR pathway inhibitors as therapy for
epidermal growth factor receptor inhibitor-resistant non-small-cell
lung cancer. Clin Lung Cancer. 14:322–332. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang C, Lan T, Hou J, Li J, Fang R, Yang
Z, Zhang M, Liu J and Liu B: NOX4 promotes non-small cell lung
cancer cell proliferation and metastasis through positive feedback
regulation of PI3K/Akt signaling. Oncotarget. 5:4392–4405. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yin H, Sun Y, Wang X, Park J, Zhang Y, Li
M, Yin J, Liu Q and Wei M: Progress on the relationship between
miR-125 family and tumorigenesis. Exp Cell Res. 339:252–260. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Duroux-Richard I, Pers YM, Fabre S, Ammari
M, Baeten D, Cartron G, Touitou I, Jorgensen C and Apparailly F:
Circulating miRNA-125b is a potential biomarker predicting response
to rituximab in rheumatoid arthritis. Mediators Inflamm.
2014:3425242014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cui F, Li X, Zhu X, Huang L, Huang Y, Mao
C, Yan Q, Zhu J, Zhao W and Shi H: MiR-125b inhibits tumor growth
and promotes apoptosis of cervical cancer cells by targeting
phosphoinositide 3-kinase catalytic subunit delta. Cell Physiol
Biochem. 30:1310–1318. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Komaki R, Allen PK, Wei X, Blumenschein
GR, Tang X, Lee JJ, Welsh JW, Wistuba II, Liu DD and Hong WK:
Adding erlotinib to chemoradiation improves overall survival but
not progression-free survival in stage III non-small cell lung
cancer. Int J Radiat Oncol Biol Phys. 92:317–324. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Edelman MJ, Tan MT, Fidler MJ, Sanborn RE,
Otterson G, Sequist LV, Evans TL, Schneider BJ, Keresztes R, Rogers
JS, et al: Randomized, double-blind, placebo-controlled,
multicenter phase II study of the efficacy and safety of apricoxib
in combination with either docetaxel or pemetrexed in patients with
biomarker-selected non-small-cell lung cancer. J Clin Oncol.
33:189–194. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Su S, Li T, Lu B, Wang X, Li J, Chen M, Lu
Y, Bai Y, Hu Y, Ouyang W, et al: Three-dimensional radiation
therapy to the primary tumor with concurrent chemotherapy in
patients with stage IV non-small cell lung cancer: Results of a
multicenter phase 2 study from PPRA-RTOG, China. Int J Radiat Oncol
Biol Phys. 93:769–777. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
van Gool MH, Aukema TS, Schaake EE, Rijna
H, Codrington HE, Valdés Olmos RA, Teertstra HJ, van Pel R, Burgers
SA, van Tinteren H, et al: 18F-fluorodeoxyglucose
positron emission tomography versus computed tomography in
predicting histopathological response to epidermal growth factor
receptor-tyrosine kinase inhibitor treatment in resectable
non-small cell lung cancer. Ann Surg Oncol. 21:2831–2837. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Guo Y, Chang H, Li J, Xu XY, Shen L, Yu ZB
and Liu WC: Thymosin alpha 1 suppresses proliferation and induces
apoptosis in breast cancer cells through PTEN-mediated inhibition
of PI3K/Akt/mTOR signaling pathway. Apoptosis. 20:1109–1121. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Paul A, Bishayee K, Ghosh S, Mukherjee A,
Sikdar S, Chakraborty D, Boujedaini N and Khuda-Bukhsh AR:
Chelidonine isolated from ethanolic extract of Chelidonium majus
promotes apoptosis in HeLa cells through p38-p53 and PI3K/AKT
signalling pathways. Zhong Xi Yi Jie He Xue Bao. 10:1025–1038.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang Y, Chen L, Huang G, He D, He J, Xu W,
Zou C, Zong F, Li Y, Chen B, et al: Klotho sensitizes human lung
cancer cell line to cisplatin via PI3k/Akt pathway. PLoS One.
8:e573912013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xu R, Shang C, Zhao J, Han Y, Liu J, Chen
K and Shi W: Activation of M3 muscarinic receptor by acetylcholine
promotes non-small cell lung cancer cell proliferation and invasion
via EGFR/PI3K/AKT pathway. Tumour Biol. 36:4091–4100. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shi L, Fei X, Wang Z and You Y: PI3K
inhibitor combined with miR-125b inhibitor sensitize TMZ-induced
anti-glioma stem cancer effects through inactivation of
Wnt/β-catenin signaling pathway. In Vitro Cell Dev Biol Anim.
51:1047–1055. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Carotenuto M, De Antonellis P, Liguori L,
Benvenuto G, Magliulo D, Alonzi A, Turino C, Attanasio C, Damiani
V, Bello AM, et al: H-Prune through GSK-3β interaction sustains
canonical WNT/β-catenin signaling enhancing cancer progression in
NSCLC. Oncotarget. 5:5736–5749. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Katoh M: WNT/PCP signaling pathway and
human cancer (Review). Oncol Rep. 14:1583–1588. 2005.PubMed/NCBI
|
|
28
|
Zheng H, Saito H, Masuda S, Yang X and
Takano Y: Phosphorylated GSK3β-ser9 and EGFR are good
prognostic factors for lung carcinomas. Anticancer Res.
27:3561–3569. 2007.PubMed/NCBI
|
|
29
|
Jiang HL, Jiang LM and Han WD:
Wnt/β-catenin signaling pathway in lung cancer stem cells is a
potential target for the development of novel anticancer drugs. J
BUON. 20:1094–1100. 2015.PubMed/NCBI
|
|
30
|
Gao Y, Song C, Hui L, Li CY, Wang J, Tian
Y, Han X, Chen Y, Tian DL, Qiu X, et al: Overexpression of
RNF146 in non-small cell lung cancer enhances proliferation
and invasion of tumors through the Wnt/β-catenin signaling pathway.
PLoS One. 9:e853772014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li GH, Cui YS, Wu QY, Zhang XJ and Gao YF:
Clinicopathologic significance of β-catenin and matrix
metalloproteinase-2 expression in non-small cell lung cancer. Med
Oncol. 30:4372013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen CH, Chuang SM, Yang MF, Liao JW, Yu
SL and Chen JJ: A novel function of YWHAZ/β-catenin axis in
promoting epithelial-mesenchymal transition and lung cancer
metastasis. Mol Cancer Res. 10:1319–1331. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lee SB, Park YI, Dong MS and Gong YD:
Identification of 2,3,6-trisubstituted quinoxaline derivatives as a
Wnt2/β-catenin pathway inhibitor in non-small-cell lung cancer cell
lines. Bioorg Med Chem Lett. 20:5900–5904. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zang B, Huang G, Wang X and Zheng S:
HPV-16 E6 promotes cell growth of esophageal cancer via
downregulation of miR-125b and activation of Wnt/β-catenin
signaling pathway. Int J Clin Exp Pathol. 8:13687–13694.
2015.PubMed/NCBI
|
